MODEYSO Trademark

Trademark Overview

On Friday, April 21, 2023, a trademark application was filed for MODEYSO with the United States Patent and Trademark Office. The USPTO has given the MODEYSO trademark a serial number of 97901513. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, June 24, 2026. This trademark is owned by Chimerix, Inc.. The MODEYSO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and pharmaceutical preparations for use in the treatment of oncological and neurological diseases and disorders
modeyso

General Information

Serial Number97901513
Word MarkMODEYSO
Filing DateFriday, April 21, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, June 24, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements

Goods and ServicesPharmaceuticals and pharmaceutical preparations for use in the treatment of oncological and neurological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 18, 2023
Primary Code005
First Use Anywhere DateFriday, August 15, 2025
First Use In Commerce DateFriday, August 15, 2025

Trademark Owner History

Party NameChimerix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27713
US
Party NameChimerix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713
US

Trademark Events

Event DateEvent Description
Tuesday, April 25, 2023NEW APPLICATION ENTERED
Thursday, May 18, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 6, 2024ASSIGNED TO EXAMINER
Saturday, January 6, 2024NON-FINAL ACTION WRITTEN
Saturday, January 6, 2024NON-FINAL ACTION E-MAILED
Saturday, January 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 4, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, March 4, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, June 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 20, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 16, 2024ASSIGNED TO LIE
Wednesday, October 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 4, 2025SOU TEAS EXTENSION RECEIVED
Monday, August 4, 2025SOU EXTENSION 1 FILED
Monday, August 4, 2025SOU EXTENSION 1 GRANTED
Tuesday, August 5, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 21, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, February 10, 2026SOU TEAS EXTENSION RECEIVED
Monday, June 22, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 9, 2026SOU EXTENSION 2 FILED
Wednesday, June 24, 2026SOU EXTENSION 2 GRANTED
Tuesday, October 21, 2025USE AMENDMENT FILED
Wednesday, June 24, 2026STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 24, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 24, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 24, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

modeyso neurological diseases disorders oncological treatment pharmaceutical preparations pharmaceuticals